Shenzhen New Industries Biomedical (300832) — Cash Flow-to-Debt Ratio
Shenzhen New Industries Biomedical (300832) has a Cash Flow-to-Debt Ratio of 0.73x as of September 2025, meaning its operating cash flow of CN¥606.21 Million could theoretically repay 1% of its total liabilities (CN¥831.98 Million) in one year. See cash generation quality of Shenzhen New Industries Biomedical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen New Industries Biomedical Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Shenzhen New Industries Biomedical across 13 annual periods. Also explore 300832 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shenzhen New Industries Biomedical (2012–2024)
Year-by-year debt coverage analysis for Shenzhen New Industries Biomedical. For market capitalisation and broader financial context, see Shenzhen New Industries Biomedical (300832) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.30x | CN¥1.36 Billion | CN¥1.04 Billion | ▼ -37.8% |
| 2023 | 2.09x | CN¥1.42 Billion | CN¥678.09 Million | ▲ +33.7% |
| 2022 | 1.56x | CN¥962.39 Million | CN¥615.06 Million | ▲ +5.9% |
| 2021 | 1.48x | CN¥773.22 Million | CN¥523.51 Million | ▼ -24.2% |
| 2020 | 1.95x | CN¥976.65 Million | CN¥501.49 Million | ▼ -25.3% |
| 2019 | 2.61x | CN¥831.73 Million | CN¥318.92 Million | ▲ +2.0% |
| 2018 | 2.56x | CN¥701.97 Million | CN¥274.52 Million | ▲ +21.8% |
| 2017 | 2.10x | CN¥524.73 Million | CN¥250.00 Million | ▼ -19.9% |
| 2016 | 2.62x | CN¥486.81 Million | CN¥185.75 Million | ▲ +7.0% |
| 2015 | 2.45x | CN¥305.93 Million | CN¥124.94 Million | ▲ +30.3% |
| 2014 | 1.88x | CN¥253.47 Million | CN¥134.92 Million | ▲ +120.2% |
| 2013 | 0.85x | CN¥138.33 Million | CN¥162.12 Million | ▼ -0.7% |
| 2012 | 0.86x | CN¥55.80 Million | CN¥64.93 Million | — |